The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

A new study finds that offering these patients pain coping skills training (PCST) significantly reduced their suffering and ...

People undergoing hemodialysis for kidney failure often experience chronic pain related to their condition. However, managing ...

We all feel a little chilly from time to time, whether it's from cold temperatures or blustery wind. But if you find yourself wondering, "Why are my hands always cold?," an underlying health condition ...